Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Are long-term hormone replacement therapy users different from short-term and never users?

Buist DS, LaCroix AZ, Newton KM, Keenan NL.

Am J Epidemiol. 1999 Feb 1;149(3):275-81.

PMID:
9927224
2.

Menopausal experiences and hormone replacement therapy use among women with physical impairments.

Becker H, Stuifbergen AK, Gordon D.

Womens Health Issues. 2002 Jul-Aug;12(4):212-9.

PMID:
12093585
3.

Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Lambert LJ, Straton JA, Knuiman MW, Bartholomew HC.

J Epidemiol Community Health. 2003 Apr;57(4):294-300.

4.

Hormone replacement and menopausal symptoms following hysterectomy.

Langenberg P, Kjerulff KH, Stolley PD.

Am J Epidemiol. 1997 Nov 15;146(10):870-80.

PMID:
9384207
5.

Why do women doctors in the UK take hormone replacement therapy?

Isaacs AJ, Britton AR, McPherson K.

J Epidemiol Community Health. 1997 Aug;51(4):373-7.

6.

Hormone replacement therapy and glucose tolerance in EPIC-Norfolk: a population-based study.

Sargeant LA, Wareham NJ, Khaw KT.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):20-5.

PMID:
10707035
7.

Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.

Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD; Women's Health in Lund Area (WHILA) Study.

Menopause. 2000 Jul-Aug;7(4):273-81.

PMID:
10914621
8.

Women's knowledge of and attitudes towards hormone replacement therapy.

Lewin KJ, Sinclair HK, Bond CM.

Fam Pract. 2003 Apr;20(2):112-9.

PMID:
12651782
9.

Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.

Amigoni S, Morelli P, Chatenoud L, Parazzini F.

Climacteric. 2000 Mar;3(1):25-32.

PMID:
11910606
10.

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P.

Thromb Res. 2001 Jan 15;101(2):35-43.

PMID:
11342204
11.
12.

Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.

Lucas R, Barros H.

Maturitas. 2007 Jul 20;57(3):226-32. Epub 2007 Feb 12.

PMID:
17293067
13.

Sociodemographic and clinical factors associated with HRT use in women attending menopause clinics in Italy.

Pansini F, Bacchi Modena AB, de Aloysio D, Gambacciani M, Meschia M, Parazzini F, Sciacchitano G, di Micco R, Peruzzi E, Maiocchi G; ICARUS Study Group.

Climacteric. 2000 Dec;3(4):241-7.

PMID:
11910583
14.

Impact of hormone replacement therapy on the body mass and fat compositions of menopausal women: a cross-sectional study.

Sayegh RA, Kelly L, Wurtman J, Deitch A, Chelmow D.

Menopause. 1999 Winter;6(4):312-5.

PMID:
10614678
15.

Understanding attitudes of older women toward hormone replacement therapy.

Phelan EA, Buist DS, Anderson LA, Newton KM, Delaney KM, LaCroix AZ.

Prev Med. 2001 Jan;32(1):49-56.

PMID:
11162326
16.

Patterns and correlates of hormone replacement therapy use among middle-aged Australian women.

France K, Schofield MJ, Lee C.

Womens Health. 1997 Summer;3(2):121-38.

PMID:
9332154
17.
18.

Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.

Vinker S, Kaplan B, Yaphe J, Cohen O, Shumla V, Shapira G, Shofty I, Kitai E.

Climacteric. 2003 Mar;6(1):75-80.

PMID:
12725667
19.
20.

Menopausal hormone therapy decisions: insights from a multi-attribute model.

Schapira MM, Gilligan MA, McAuliffe TL, Nattinger AB.

Patient Educ Couns. 2004 Jan;52(1):89-95.

PMID:
14729295

Supplemental Content

Support Center